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Changes in hepatic haemodynamics in rats with overt liver tumour
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Summary Overt liver tumour was induced in Fisher rats by intraportal administration of 1.6 x 107 Walker
carcinosarcoma cells. Control groups of rats received similar volumes of dead cells or saline intraportally. All
animals were studied at 3 weeks when overt tumour was present. The Hepatic Perfusion Index (HPI) was
significantly raised in rats with overt tumour compared to both groups of control animals. Portal flow and
portal venous inflow were significantly reduced in the presence of overt tumour but hepatic arterial flow did
not alter. These observations suggest that the alteration in the HPI in the presence of overt tumour results
from an alteration in portal venous flow and inflow even though the blood supply to the tumour is principally
derived from the hepatic artery. The changes in hepatic haemodynamics in the presence of tumour were
accompanied by a reduction in portal pressure, an increase in splanchnic vascular resistance and an increase in
the degree of arteriovenous shunting through the liver. Portal vascular resistance was unchanged. These
findings indicate that the presence of overt hepatic tumour results in gross derangements ofhepatic blood flow.
These changes must be taken into consideration when attempting to potentiate the delivery of cytotoxic drugs
to hepatic tumour by manipulation of hepatic haemodynamics.
The hepatic perfusion index (HPI), that is the ratio ofhepatic
arterial to total hepatic blood flow determined by dynamic
scintigraphy is elevated in the presence of overt tumour in
man (Leveson et al., 1983). Previous studies have suggested
that the blood supply to overt liver tumour is derived princi-
pally from the hepatic artery (Taylor et al., 1979). Conse-
quently, it has been assumed that the elevations in the HPI in
patients with overt hepatic metastases is related to increases
in hepatic artery flow per se. However, this hypothesis cannot
be substantiated in man because ofthe technical difficulties in
accurately measuring the various components of hepatic
haemodynamics. Therefore, the aim of this study was to
establish the changes in hepatic haemodynamics responsible
for alterations in the HPI in rats with overt hepatic tumour
derived from the intraportal injection of Walker carcinosar-
coma cells.
Materials and methods
Inducation ofmetastases
Walker 256 carcinosarcoma cells were grown in suspension in
Williams E Medium (Flow Laboratories Ltd., Rickmans-
worth, UK) supplemented with 5% foetal calf serum at 37'C
in a 5% CO2 humidified atmosphere. Ninety male Fisher rats
approximately 300 g in weight were anaesthetised with intra-
peritoneal sodium pentobarbitone (6 mg 100 g-' body
weight) and the portal vein exposed through a midline
incision. Thirty rats received an intraportal inoculation of
1.6 x 107 Walker carcinosarcoma cells in a volume of 0.2 ml,
over a period of 10 s using a 2FG gauge needle. The needle
was held in position in the portal vein for approximately 30 s
after completion of the injection to minimise the risk of
spillage of cells into the peritoneal cavity. Haemostasis was
achieved by compression of the portal vein for 30 s. Another
group of 30 rats received an intraportal injection of the same
volume of deal cells. These were obtained by growing the
cells in the incubator and then placing them in a fridge at
4'C for 4 days. Non-viability was then confirmed using
trypan blue exclusion. A further group of 30 rats received an
intraportal injection of the same volume of isotonic saline.
The abdomen was closed in two layers and the animals
allowed to recover. All haemodynamic studies were carried
out 3 weeks after the intraportal injection of either viable or
dead Walker cells or saline.
Radionuclide studies
Ten rats injected intraportally with either viable Walker cells
or the same number of dead Walker cells and ten rats
receiving saline were anaesthetised with intraperitoneal
sodium pentobarbitone and the right common carotid artery
exposed through a midline cervical incision. A 10 cm length
2FG polyethylene cannula was introduced into the carotid
artery via an arteriotomy. The cannula was screened into
position in the left ventricle using a Siemens Siremobile
(Siemens Ltd., Sunbury-on-Thames, UK) image intensifier
such that its tip was approximately 1 mm below the aortic
valve. Adequate expulsion of a small bolus of injectate by the
left ventricle was confirmed by injecting 0.1 ml Sodium Meg-
lumine via the cannula. The rats were then placed under an
N.E.8900 Gamma camera (Nuclear Enterprises Ltd., Edin-
burgh, UK) with a 1 cm pinhole collimator linked to a PDP
DEK computer (Digital Equipment Corporation, Maynard,
Massachusetts, USA). 9'9Tc sulphur colloid (0.04 ml) with an
activity of 80 MBq was injected rapidly as a bolus into the
left ventricle using a 50 tl High Pressure Liquid Chromatog-
raphy syringe. Images were acquired at three frames per
second and stored on hard disc for subsequent analysis. A
compositie image of the first five frames of each study was
constructed and regions of interest (ROI) were drawn arqund
the left ventricle, right kidney and right lobe of the liver as
previously described in detail (Nott et al., 1989).
Time activity curves were then generated from these ROIs
and each curve was subjected to a maximum of three quad-
ratic smooths. In first pass studies it is assumed that the
bolus of radioisotope reaches the hepatic artery and the renal
artery at the same time. Therefore the hepatic arterial phase
was taken to begin at the start of the kidney arterial phase
and extended to the peak of the kidney time activity curve.
The portal phase was taken to begin at the peak of the
kidney curve and end at the point of recirculation as pre-
viously described in detail (Nott et al., 1989). The HPI was
derived from the gradients of the arterial (GI) and portal
phases (G2)of the liver perfusion curves using the equation:
HPI= GI
GI + G2
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Haemodynamic measurements
Microsphere technique
Immediately after the completion of the dynamic scinti-
graphic studies, hepatic and splanchnic blood flow was deter-
mined using the radiolablled microsphere technique (Mc-
Devitt & Nies, 1976). Briefly, the right and left femoral
arteries were cannulated with 2FG Portex cannula (10 cm in
length). The cannula in the left femoral artery was connected
to a physiological pressure transducer for the continuous
measurement of blood pressure and pulse. The right femoral
artery cannula was connected to a Sage 351 (Orien Research
Incorporated, Cambridge, Massachusetts, USA) withdrawal
pump. A reference blood sample was withdrawn from the
femoral artery over a 70 s period. Ten seconds after the start
of blood withdrawal, each rat received an intraventricular
injection of 60,000-80,000 57Co Nen-Trac microspheres
(16.4 ± 1 microns) suspended in 0.9% N. Saline with 0.01%
tween (New England Nuclear, Stevenage, UK), in a volume
of 0.4 ml over 20 s. Prior to the injection the microspheres
were sonicated for 10 min and then vibrated on the side of a
vortex mixer immediately before injection to ensure complete
disaggregation of the spheres.
The animals were killed by an overdose of sodium pento-
barbitone, 5 min after microsphere injection, the organs
removed, weighed, placed in counting vials, and left in a
refrigerator for a minimum of 7 days until the 9'9Technetium
had decayed to an insignificant amount. The vials were then
placed in a Philips PW 4580 Automatic gamma well counter
(Pye Unicam Ltd., Cambridge, UK), and the radioactivity
counted. Cardiac output and liver blood flow were deter-
mined by the method of McDevitt and Nies, 1976). Portal
venous inflow was calculated by adding together the flows to
the spleen, pancreas and splanchnic organs. If the blood flow
to the right and left kidney differed by more than 10% the
distribution of microspheres was not considered to be
uniform and the results discarded.
Corrected hepatic arterialflow
The development of overt tumour in rats receiving viable
tumour cells may underestimate hepatic arterial flow as a
result of microspheres passing via arteriovenous shunts from
the liver to the lung. The possible source of error was cor-
rected for by using the formula:
Corrected Hepatic Arterial Flow (HAFc)= Liver blood flow
(ml min -)+ lung blood flow (ml min') -mean lung blood
flow in control rats (ml min-1).
Ratio oftumour to liver arterial bloodflow
After completion of the measurement of total hepatic blood
flow by the microsphere method, the normal liver tissue and
tumour tissue were separated by careful dissection and
weighed. The radioactivity in normal liver and tumour tissue
was counted in a Philips well counter to derive a tumour/
normal liver (T/L) ratio.
Electromagneticflowmetry
Ten animals injected intraportally with either viable or dead
Walker cells or saline were anaesthetised with sodium pento-
barbitone and the femoral artery exposed and cannulated
with a 10 cm length of Portex tubing. The femoral artery
cannula was connected to a pressure transducer for contin-
uous recording of blood pressure. Through a midline incision
the duodenal loop was exposed and the portal vein and
hepatic artery carefully mobilised. Electromagnetic flow pro-
bes of appropriate size (Gould Medical Ltd., Lutterworth,
UK) were placed around the portal vein cranial to its junc-
tion with the pancreaticoduodenal vein and around the hepa-
tic artery. The flow probes were zeroed in vivo by occluding
the vessels distal to the probes. Blood flow in both the portal
vein and the hepatic artery were recorded using a Gould
Flowmeter (Model SP2202, Gould Medical Ltd., Lutter-
worth, UK).
Portalpressure
Immediately after measurement of the portal venous and
hepatic artery flows by electromagnetic flowmetry, the probes
were removed. The portal vein was cannulated retrogradely
using a 2FG paediatric venflon 2 cm below the porta hepatis
so that the tip of the cannula layjust above the confluence of
the splenic and portal veins. No mobilisation of the liver was
required for the procedure and hepatic trauma was avoided
during insertion of the cannula.
Splanchnic and portal venous resistances were calculated
from the following equations:
Spanchnic vascular resistance=
Mean arterial blood pressure(mmHg)
Portal venous flow (mlmin')
Portal vascular resistance =
Portal pressure (mmHg)
Portal venous flow (mlmin-')
Measurement ofintrahepatic arteriovenous shunting
Intrahepatic shunting was assessed using two methods.
(1) The lung:liver ratio of "Co after completion of the
microsphere determination of hepatic and splanchnic haemo-
dynamics was used to calculate the degree of intrahepatic
arteriorvenous shunting:
Activity in lungs cpmg- x 100 Arteriovenous Activity liver cpm-' g-'
(2) Ten rats injected intraportally with either dead Walker
cells or saline were anaesthetised with intraperitoneal sodium
pentobarbitone. Through a midline incision the coeliac, hepa-
tic, gastroduodenal and pancreaticoduodenal arteries were
exposed.
The distal gastroduodenal artery was ligated with 7/0 silk
at its junction with the pancreaticoduodenal artery. A 10 cm
long 2 Fr Portex cannula was inserted via an arteriotomy in
the gastroduodenal artery and carefully positioned so that its
tip lay just distal to the origin of the coeliac and hepatic
arteries. A sodium iodide scintillation counter linked to a
scalar ratemeter and computer, was placed over the rat's
thorax and screened from the abdomen by a lead screen.
Under direct vision using an operating microscope 0.05 ml of
9'Tc methylene diphosphonate (9Tc-MDP) was injected via
the hepatic artery cannula over 10 s at physiological pres-
sures (using a high pressure liquid chromatography syringe).
The amount of radioactivity passing to the lungs was
measured by the scintillation counter. Since 9"Tc-MDP is
not retained within the liver, the majority passes to the lungs
and is registered graphically by the computer as a 100%
passing fraction. The 99"Tc-MDP therefore acts as a reference
injection. Following administration of the 9'Tc-MDP, 0.05
ml 99mTc-macroaggragated albumen (99'Tc-MAA) mean dia-
meter 25 microns (range 15-35 microns) were administered
via the cannula using a high pressure liquid chromatography
syringe over l0 s. Unlike 991Tc-MDP, macroaggregated albu-
men is trapped within the liver sinusoids and only those
particles passing through the liver via arteriovenous shunts
appear in the lung field of interest. The percentage passing
fraction of 99"Tc-MAA passing through the liver is repre-
sented as a percentage of the passing fraction of the reference
injection of 99mTc-MDP. Previous studies have indicated an
excellent correlation (r = 0.94) between this method of
measuring intrahepatic arteriovenous shunting and that
evaluated by the more classical method using microspheres.
Statistical anaysis
Results are expressed as the mean ± s.d. Statistical differences
in hepatic haemodynamics between the rats with overt1090 D.M. NOTT et al.
tumour and control animals were evaluated using a Mann
Whitney U test.
Results
Tumour weight
All rats injected with Walker cells developed overt tumour
during the 3 weeks experimental period. However, there was
a wide variation in the number (14-26) size, and weight of
the tumour between individual rats (6.48 ± 2.44 g,
Mean ± s.d. range 1.93-10.11 g). Rats injected with dead
Walker cells did not develop any hepatic tumour.
Hepaticperfusion index
The hepatic perfusion index in control rats was significantly
less (P<0.01) than those with overt tumour (Figure 1).
Changes in hepatic haemodynamics
The hepatic arterial blood flow and the corrected hepatic
arterial blood flow were not significantly different between
rats with overt tumour and controls measured by either
electromagnetic flowmetry or the microsphere technique. In
contrast, portal venous inflow (microspheres) and portal flow
(electromagnetic flowmetry) were significantly reduced
(P<0.001) in rats with overt tumour compared to controls.
Although there was no significant difference in cardiac out-
put between the two groups, lung blood flow was signifi-
cantly increased in rats with overt tumour compared to
controls (P<0.02) (Table I).
The reduction in portal venous flow in rats with overt
tumour was accompanied by a reduction in portal pressure.
Consequently, there was no significant difference in portal
vascular resistance between rats with tumour and control
rats. Conversely, splanchnic vascular resistance was signi-
ficantly increased in rats with overt tumour compared to
controls (Table II).
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Table I Hepatic artery, portal venous inflow and splanchnic blood
flow in controls and animals with overt hepatic tumour using the
microsphere method
Saline controls Dead cells Overt metastases
n= 10 n= 10 n= 10
Hep. artery flow
(mlmin-')
Portal venous inflow
(ml min-')
Spleen
(ml min-')
Pancreas
(ml min- )
Stomach
(ml min ')
Small bowel
(ml min-')
Large bowel
(ml min-')
Lungs
(ml min-')
Cardiac output
(ml min-')
3.24±1.64 3.19± 1.75 3.53± 1.37
12.53±3.18 12.37±2.97 6.71±0.86***
0.93±0.82 0.95±0.72 0.79±0.39
1.31 ±0.95 1.29±0.72 0.87± 0.52**
1.59±0.68 1.62±0.48 0.79±0.36*
6.22± 1.86 6.23± 2.95 2.76±0.76***
3.73±1.11 3.41 ± 1.32 1.47±0.39***
0.83±0.07 0.78±0.14 1.18±0.49**
76.48± 5.38 77.39± 8.37 68.51 ±8.11
The results areexpressed as mean + I Standard Deviation. Asterisks
denote a significant difference between the two groups of animals:
***P<0.001; **P<0.02; *P = 0.05 (Mann Whitney U test).
Table II Hepatic artery and portal vein flow in controls and animals
with overt tumour measured using electromagnetic flowmetry
Saline controls Dead cells Overt metastases
n= 10 n= 10 n= 10
Hepatic artery flow 3.32±0.42 3.21±0.38 3.27±0.58
(ml min'l)
Portal flow 16.27±1.36 16.99±2.11 11.88± 1.45***
(ml min-')
Portal pressure 8.83± 1.13 8.87± 1.48 5.44± 2.11**
(mmHg)
Splanchnic vascular 6.82±0.72 6.73±0.46 9.59± 2.99*
resistance
(mmHg ml-' min)
Portal venous 0.52±0.16 0.57±0.14 0.46±0.21
resistance
(mmHg ml-' min)
The results are expressed as mean + 1 Standard Deviation. Asterisks
denote a significant difference between the two groups of animals:
***P<0.001; **P<0.02; *P + 0.05 (Mann Whitney U test).
Tumour:liver ratio
The tumour:liver ratio of cobalt microspheres was 1.18 +
0.18.
Intrahepatic shunting
Following intraventricular administration of the micro-
spheres there was a significant increase (P<0.001) in the
lung:liver ratio of 57Co in rats with overt tumour (0.36 +
0.11) compared to control rates (0.22 + 0.07) indicative of
increased intrahepatic arteriovenous shunting. similarly, the
passage of 9'Tc-MAA was significantly higher in rats with
overt tumour than control rats (Figure 2).
Discussion
The results of this study confirm previous observations in
man that the HPI determined by dynamic scintigraphy is
altered in the presence of hepatic tumours (Leveson et al.,
1985). There was no correlation between the size of the
tumours and changes in the HPI. Indeed the elevations in the
HPI were of a similar magnitude to those observed in rats
with micrometastatic tumour derived from intraportal admin-
istration ofWalker cells (Nott et al., 1989). Furthermore, our
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Figure 1 Hepatic Perfusion Index in control rats and animals
with overt hepatic tumour. The vertical bars represent the Stan-
dard Deviation of the mean.
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Figure 2 Percentage passage of MAA through the liver in rats
with overt tumour compared to controls. The vertical bars repre-
sent the Standard Deviation of the mean.
results support previous suggestions that the blood supply to
hepatic tumour tissue is principally derived from the hepatic
artery (Taylor et al., 1979). The increase in the HPI in the
presence of overt liver tumour is not however related to the
changes in the hepatic arterial flow per se as was previously
suggested (Leveson et al., 1985), since this was not signi-
ficantly different between the two groups of control animals
and those with tumour. However both portal venous inflow
and portal venous flow were significantly decreased in the
presence of overt tumour suggesting that these haemodyna-
mic changes are responsible for the alterations in the HPI, at
least in the model of hepatic tumour used for this study.
However, it remains to be established whether or not altera-
tions in the HPI in patients with liver tumour are related to
alterations in hepatic artery or portal venous flows.
In the present study, the presence of overt hepatic tumour
was associated with a reduction in portal venous inflow and
flow and an increase in splanchnic vascular resistance. The
precise mechanism whereby hepatic tumour increases splanch-
nic vascular resistance is unclear. It is conceivable that the
reduction in portal venous flow and portal venous inflow and
the increase in splanchnic vascular resistance may result from
mechanical compression of the portal triads by the tumour.
In this situation, increased intrahepatic mechanical resistance
to flow should result in an increase in portal pressure and
portal vascular resistance. Indeed, we have previously demo-
nstrated that portal vascular resistance and portal pressure
are increased while portal venous flow and inflow are
decreased during the early growth and development of hepa-
tic tumour following intraportal administration of Walker
cells (Nott et al., 1989). Therefore in the presence of a large
tumour mass within the liver it might be expected that there
might be more extensive compression of the portal radicles
and further elevations in portal pressure and portal vascular
resistance. However in the present study, portal pressure was
significantly reduced in rats with overt tumour compared to
the two groups of control animals while portal vascular
resistance was not significantly different between the three
groups of animals. Therefore it would appear that any in-
crease in intrahepatic portal resistance resulting from
mechanical compression of the portal triads by the tumour
must be opposed by changes in hepatic haemodynamics
which reduce portal pressure and resistance. A possible ex-
planation for this phenomenon is that portal blood is shunt-
ed through and around the tumour by intrahepatic vascular
pathways and by the development of an extrahepatic circula-
tion which maintains portal vascular resistance at normal
levels and reduces portal pressure. In cirrhosis, the portal
pressure remains elevated despite the development of an
extensive collateral circulation because of the accompanying
hyperdynamic state, namely an increase in cardiac output
and increased splanchnic blood flow. In the present study
however, overt hepatic tumour does not induce a hyper-
dynamic state since cardiac output was unchanged and portal
venous flow and portal venous inflow were decreased. Further-
more, portal pressure is significantly decreased in the presence
of overt tumour whilst splanchnic vascular resistance is
increased. These observations therefore suggest that the pre-
sence of overt tumour in rats is associated with an increase
splanchnic vasoconstriction. The mechanisms whereby overt
hepatic tumour elicits splanchnic vasoconstriction are not
clear but may result from release of vasoactive substances.
Indeed, our own recent studies have confirmed the release of
vasoactive substances during the growth and development of
hepatic micrometastases (unpublished).
The presence of overt hepatic tumour in the rat was
accompanied by a marked increase in arteriovenous shunting
as evidenced by an increased passage of"Co and 99nTc-MAA
through the liver. These observations are therefore in accord
with a previous observation which also indicated the presence
of intrahepatic arteriovenous shunts assoicated with liver
metastases derived from colorectal carcinoma in man (Stark-
hammer et al., 1987). The precise nature of these intrahepatic
arteriovenous anastomoses is not known, but they could arise
from the 'opening up' of pre-existing shunts. Alternatively
shunts could develop de novo within or around the tumour.
Nevertheless, the existance of arteriovenous shunts in the
presence of overt tumour may explain why regional chemo-
therapy via the hepatic artery appears to have a marginal
therapeutic effect, since a large proportion of the cytotoxic
may be shunted around or through the tumour.
In summary therefore, the results of this study indicate
that overt tumour derived from the intraportal inoculation of
Walker cells results in an increase in the HPI. The blood
supply to the tumour is derived principally from the hepatic
artery. However hepatic arterial flow does not change in the
presence of tumour and the alterations in the HPI are secon-
dary to a reduction in portal venous inflow. Moreover, the
presence of overt hepatic tumour is associated with gross
derangement of hepatic haemodynamic with a pronounced
increase in intrahepatic arteriovenous shunting. The haemo-
dynamic changes accompanying the development of overt
hepatic tumour are complex and must be taken into account
when attempting to potentiate the distribution of cytotoxics
to the tumour by regional administration or through manip-
ulation of liver blood flow.
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